Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Nov;144(5):486-499.
doi: 10.1111/ane.13493. Epub 2021 Jun 30.

Neutrophil-lymphocyte ratio in acute ischemic stroke: Immunopathology, management, and prognosis

Divyansh Sharma  1   2 , Kevin J Spring  2   3   4 , Sonu Menachem Maimonides Bhaskar  1   3   5
Affiliations
Review

Neutrophil-lymphocyte ratio in acute ischemic stroke: Immunopathology, management, and prognosis

Divyansh Sharma et al. Acta Neurol Scand. 2021 Nov.

Abstract

There is an ongoing need for accurate prognostic biomarkers in the milieu of acute ischemic stroke (AIS) receiving reperfusion therapy. Neutrophil-lymphocyte ratio (NLR) has been implicated in emergency medicine and acute stroke setting as an important biomarker in the prognosis of patients. However, there are ongoing questions around its accuracy and translation into clinical practice given suboptimal sensitivity and specificity results, as well as varying thresholds and lack of clarity around which NLR time points are most clinically indicative. This article provides a comprehensive overview of the role of NLR in AIS patients receiving reperfusion therapy and perspectives on areas of future research. NLR may be an important biomarker in risk stratifying patients in AIS to identify and select those who are more likely to benefit from reperfusion therapy. Appropriate clinical decision-making tools and models are required to harness the predictive value of NLR, which could be useful in identifying and monitoring high-risk patients to guide early treatment and achieve improved outcomes. Our understanding of the role of NLR in the immunopathogenesis of AIS is also suboptimal, which hinders the ability to translate this into clinical practice.

Keywords: acute ischemic stroke; clinical decision making; immunopathogenesis; neutrophil-lymphocyte ratio; pathophysiology; prognosis; reperfusion therapy.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

REFERENCES

    1. Planas AM. Role of immune cells migrating to the ischemic brain. Stroke. 2018;49(9):2261-2267.
    1. Meng L, Wang H, Yang H, et al. Nomogram to predict poor outcome after mechanical thrombectomy at older age and histological analysis of thrombus composition. Oxid Med Cell Longev. 2020;2020:e8823283.
    1. Berchtold D, Priller J, Meisel C, Meisel A. Interaction of microglia with infiltrating immune cells in the different phases of stroke. Brain Pathol. 2020;30(6):1208-1218.
    1. Jian Z, Liu R, Zhu X, et al. The involvement and therapy target of immune cells after ischemic stroke. Front Immunol. 2019;10:2167.
    1. Xu S, Lu J, Shao A, Zhang JH, Zhang J. Glial cells: role of the immune response in ischemic stroke. Front Immunol. 2020;11:294.

Grants and funding

LinkOut - more resources